Previous studies demonstrated that Lgr5 is overexpressed in hepatocellular carcinoma[10], colorectal cancer[12,13], ovarian cancer[13], basal cell carcinoma[14], and esophageal adenocarcinoma[15]. Here, LGR5 is linked to hepatocellular carcinoma.